| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | SVP, Drug Development
1 company
Rosenbaum David P. is a Chief Development Officer at ARDELYX, INC.. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 2,013 | $0.67 | $1,351.53 | -0.4% | +62.3% | +443.5% | |
| Feb 22, 2022 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 2,353 | $0.67 | $1,576.51 | -0.5% | -7.6% | +332.8% | |
| Nov 22, 2021 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 827 | $0.99 | $820.28 | -0.2% | -26.8% | +98.6% | |
| Aug 20, 2021 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 807 | $1.32 | $1,065.24 | -0.4% | -26.3% | -23.9% | |
| May 28, 2021 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 3,062 | $7.22 | $22,098.15 | -10.3% | -79.7% | -90.8% | |
| May 20, 2021 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 769 | $7.09 | $5,450.52 | -0.4% | -79.9% | -90.4% | |
| Apr 6, 2021 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 5,000 | $8.00 | $40,000.00 | -3.0% | +7.9% | -85.7% | |
| Feb 22, 2021 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 805 | $6.88 | $5,540.41 | -0.4% | +0.4% | -90.1% | |
| Sep 15, 2020 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 38,126 | $5.52 | $210,432.27 | -19.8% | - | - | |
| Jun 4, 2019 | ARDX Ardelyx, Inc. | Chief Development Officer | Sell | 2,856 | $2.54 | $7,258.24 | -1.8% | - | - |